Implementing a clinical practice guideline helps children with pneumonia get proper antibiotics
About 2 percent of children will
contract community-acquired
pneumonia (CAP) each year.
National guidelines recommend
ampicillin (a narrow-spectrum
antibiotic) to treat children
hospitalized with uncomplicated
CAP. This antibiotic targets the
bacteria Streptococcus pneumonia,
which causes most cases of
pediatric CAP.
The researchers examined the
impact of a large children's
hospital's implementation of a
clinical practice guideline that
encouraged the use of ampicillin
followed by the narrow-spectrum
antibiotic amoxicillin at the time of
hospital discharge for 5 to 7 days.
Implementing the new guideline
resulted in an increased use of
ampicillin and a decline in use of
broad-spectrum antibiotics (that
target many types of bacteria) at
hospital discharge.
The researchers collected data on
530 children hospitalized with CAP
for 12 months prior to guideline
implementation and on 503
children after the guideline was put
into place. Prior to guideline
implementation, 72 percent of
children were treated with
ceftriaxone; only 13 percent were
treated with ampicillin. After 1 year
of guideline implementation, the
most commonly used antibiotic was
ampicillin (63 percent). Overall,
there was a 34 percent increase in
the use of ampicillin following
guideline implementation.
Importantly, no increase in
treatment failures or readmissions
were observed due to this change.
The use of post-discharge
antibiotics also changed, with a
significant rise in the use of
amoxicillin and a significant
decrease in the use of cefdinir and
other antibiotics. Although the
guideline significantly improved
antibiotic choice among providers,
other recommendations such as the
length of antibiotic therapy and
obtaining blood cultures were not
followed. The study was supported
in part by the Agency for
Healthcare Research and Quality
(HS10399).
See "Impact of a guideline on
management of children
hospitalized with communityacquired
pneumonia," by Ross E.
Newman, D.O., Erin B. Hedican,
M.P.H., Joshua C. Herigon, M.P.H.,
and others in the March 2012
Pediatrics 129(3), pp. e597-e604.
—
KB
Return to Contents
Proceed to Next Article